Healthcare
So-Young International Inc.(SY)
Live Price
Offline$1.86
-5.58% today
1Y Change
+47.86%
Window
Jun 20, 2025 โ Jun 16, 2026
- Market Cap
- $2.70B
- Revenue Growth
- +1.0%
- EPS Growth
- +59.6%
- Dividend Yield
- 0.0%
Coverage: 248 bars ยท Jun 20, 2025 โ Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
So-Young International Inc. (SY) is a Healthcare stock with a market cap of $2.70B and listed on NASDAQ. The stock last traded around $1.86 and up 47.9% across the available one-year price window (Jun 20, 2025 โ Jun 16, 2026). Baseline metrics include revenue growth of +1.0%, EPS growth of +59.6%, a dividend yield of 0.0%. What stands out right now is revenue +1.0%, EPS +59.6%, free cash flow -242.5% with operating margin -17.5% and ROIC -13.4%. Valuation is more restrained than many high-expectation growth names at price/sales 1.8. Stock Foundry combines SY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
+1.0% vs +7.6% peer median
Operating Margin
Below sector median
-17.5% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 14, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +1.0% and EPS at +59.6%, with operating margin around -17.5%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged -8.9% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 14, 2026 | โ | +0.0% | -6.3% | -34.7% |
2026 Mar 25, 2026 | -33.5% | -11.3% | -13.8% | -15.4% |
2025 Nov 17, 2025 | +86.8% | +3.9% | -6.5% | -12.8% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SY
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SY Max Drawdown
-70.53%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SY and SPY.
Company Overview
So-Young International Inc.
NASDAQ Global Market
So-Young International Inc. operates an online platform for medical aesthetics and consumption healthcare services focusing on discretionary medical treatments in the People's Republic of China and internationally. Its platform enables users to discover content and share their own experience on medical aesthetics procedures and leads users to reserve treatment services from medical aesthetic service providers for offline treatment. The company facilitates research on medical aesthetic treatment trends; ratings and reviews on treatment experiences; and blogs under the name Beauty Diaries. It also provides reservation services in the areas of dermatology, dentistry and orthodontics, ophthalmology, physical examinations, gynecology, human papilloma virus vaccines, and postnatal care; Software as a Service; and guiding and consulting services through training programs for medical service providers. In addition, the company offers internet information and technology advisory, management consulting, and Internet culture services, as well as sells medical equipment; equipment production, sales, and agency services; and micro finance services. As of December 31, 2021, it had approximately 8,400 medical aesthetic service providers and 5,000 other consumption healthcare service providers on its platform. The company was founded in 2013 and is headquartered in Beijing, China.
- Leadership
- Xing Jin
- IPO Date
- May 2, 2019
- Employees
- 1.8k
- Street Address
- Ronsin Technology Center
- Mailing
- Beijing, 100102
- Region
- Beijing, CN
- Reporting Currency
- USD
- Investor Line
- 86 10 5269 9283
- Last Updated
- May 5, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 1.8
- Price/Book
- 1.7
Growth
- Revenue
- +1.0%
- EPS
- +59.6%
- Free Cash Flow
- -242.5%
Profitability
- Gross Margin
- 47.8%
- Operating Margin
- -17.5%
- Net Margin
- -15.9%
- ROE
- -14.3%
- ROIC
- -13.4%
Balance Sheet
- Debt/Equity
- 0.19
- Current Ratio
- 1.89
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.